Journal Information

Statistics

Follow this link to access the full text of the article

ORIGINALS
Cost-per-responder analysis for eltrombopag and rituximab in the treatment of primary immune thrombocytopenia in Spain
Coste de eltrombopag y rituximab por paciente respondedor al tratamiento de la trombocitopenia inmune primaria en España
José Ramón González-Porras1, Francisco Javier Parrondo García2, Eduardo Anguita3,
Corresponding author
eduardo.anguita@salud.madrid.org

Author of correspondence Eduardo Anguita Mandly Servicio de Hematología, IML, IdISSC. Hospital Clínico San Carlos. Departamento de Medicina, UCM C/ Profesor Martín Lagos s/n 28040 Madrid, Spain
1 Hematology Department, Hospital Universitario de Salamanca-IBSAL, Salamanca. Spain
2 JParrondoHEALTH. Coslada, Madrid. Spain
3 Hematology Department, IML, IdISSC; Hospital Clínico San Carlos. Medical School, Department of Medicine, Complutense University (UCM), Madrid, Spain
Read
1384
Times
was read the article
379
Total PDF
1005
Total HTML
Share statistics
Article information
ISSN: 11306343
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 May 10 5 15
2025 April 109 25 134
2025 March 107 24 131
2025 February 50 21 71
2025 January 47 22 69
2024 December 52 14 66
2024 November 59 31 90
2024 October 37 21 58
2024 September 63 16 79
2024 August 58 31 89
2024 July 51 24 75
2024 June 67 34 101
2024 May 85 35 120
2024 April 63 16 79
2024 March 33 18 51
2024 February 36 15 51
2024 January 37 5 42
2023 December 29 12 41
2023 November 12 10 22
Show all

Follow this link to access the full text of the article

Idiomas
Farmacia Hospitalaria
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.